Yes, the country’s financial system may be in total meltdown right now but your company can still benefit from the Global Cardiovascular Innovation Center (GCIC). On top of developing and acquiring new technologies, the GCIC also looks to launch new cardio companies and recruit companies with $30 million in investable cash.
The GCIC has announced the next round of the Commercialization Funding Program beginning with a formal request for proposals to be released on October 1, 2008.
GCIC is calling for proposals from companies and institutions seeking to commercialize innovative cardiovascular technologies. GCIC can provide development assistance and financial support to advance promising technologies through development and commercialization milestones.
Proposals for cardiovascular technology commercialization projects will be accepted from research institutions and companies currently located in Ohio or seeking to develop a presence in Ohio. Projects will be evaluated on technical, commercialization and economic development merits.
Proposals due on November 21, 2008.
The Global Cardiovascular Innovation Center is a $250 million product commercialization consortium made possible by a $60 million grant from the State of Ohio’s Third Frontier Project. The consortium is led by the Cleveland Clinic and includes Case Western Reserve University, the Ohio State University, the University of Cincinnati, the University of Toledo and University Hospitals of Cleveland, along with leading industry and economic development partners.
More at the GCIC website.
